LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Heron Therapeutics (NASDAQ: HRTX)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ HRTX Heron Therapeutics
Rubric Capital Management LP / 10 percent owner
08/08/2025
Buy
$1.50
2.39M
$3.581M
29.10M
NASDAQ HRTX Heron Therapeutics
Morgan Adam / director
08/08/2025
Buy
$1.50
1.77M
$2.650M
8.75M
NASDAQ HRTX Heron Therapeutics
Morgan Adam / director
08/08/2025
Buy
$1.50
70,012
$105K
70,012